Extracranial venous angioplasty is ineffective to treat MS
R Zivadinov, B Weinstock-Guttman - Nature Reviews Neurology, 2018 - nature.com
Nature Reviews Neurology, 2018•nature.com
A randomized, double-blind, sham-controlled trial, Brave Dreams, has shown no clinical or
radiological benefit of percutaneous transluminal angioplasty (PTA) to correct chronic
cerebrospinal venous insufficiency in patients with multiple sclerosis (MS). These results
finally settle the scientific debate over whether PTA can improve clinical, radiological and
symptomatic outcomes in this patient population.
radiological benefit of percutaneous transluminal angioplasty (PTA) to correct chronic
cerebrospinal venous insufficiency in patients with multiple sclerosis (MS). These results
finally settle the scientific debate over whether PTA can improve clinical, radiological and
symptomatic outcomes in this patient population.
A randomized, double-blind, sham-controlled trial, Brave Dreams, has shown no clinical or radiological benefit of percutaneous transluminal angioplasty (PTA) to correct chronic cerebrospinal venous insufficiency in patients with multiple sclerosis (MS). These results finally settle the scientific debate over whether PTA can improve clinical, radiological and symptomatic outcomes in this patient population.
nature.com
以上显示的是最相近的搜索结果。 查看全部搜索结果